Research Catalogue
Research Catalogue
Eighty-seven research listings across vials, capsules, blends, stacks, topicals and laboratory accessories, supplied for laboratory research purposes only.
The catalogue holds 87 listings, and this page is the entry point to it. Rather than reproducing every product tile, it does the job a shop page ought to do and is rarely given room to do: explain how the range is organised, what each format actually means in handling terms, what documentation comes with a batch, and how ordering and shipping work, so that the decision is made before the basket rather than after it.
Everything listed here is supplied for laboratory research purposes only. That is not a sentence bolted onto the end of a product description. It is the condition on which the catalogue exists, and it shapes what appears on this page: formats, quantities, purity standards, batch documentation, storage requirements. What you will not find is any account of what a compound is supposed to do to a person, because that question sits outside what a research supplier is entitled to answer.
The range is grouped into seven published sections. Peptide Vials is the largest, holding single compounds as lyophilised material. Peptide Capsules covers solid-format research listings. Peptide Blends holds single vials containing a defined combination. Peptide Stacks holds sets of separate vials supplied together. New Arrivals and Promotions are movable sections reflecting what has recently been added or discounted. Peptide Accessories covers the supporting laboratory items an order may need alongside the material itself.
Pricing is shown against each listing on the website, and many compounds are offered in more than one quantity with multi-pack savings of up to 20% on larger volumes. Prices and promotions change, so this page deliberately does not reproduce them; the product listing itself is the accurate source at any given moment.
Format is the first real decision in the catalogue, and it is a handling decision rather than a preference. The same compound presented two ways carries different storage requirements, different preparation steps, and different opportunities for something to go wrong at the bench. It is worth being deliberate about it.
The lyophilised vial is the standard presentation and the backbone of the range. The compound is supplied as a freeze-dried powder in a sealed vial, which gives the best stability profile for storage and leaves reconstitution volume and buffer choice entirely with the researcher. That control is the point. A material supplied dry can be prepared to whatever concentration a protocol calls for, whereas a material supplied in solution has already made that decision.
Vials are filled and sealed under controlled conditions and marked with a compound identifier, a nominal quantity, and a lot number that ties the unit back to its batch documentation. The nominal quantity is the figure shown against the listing, and where a compound is offered in several quantities, those appear as options on the product page rather than as separate listings.
Capsule-format listings present a compound in a solid, pre-portioned form. It is worth being explicit about what this does and does not mean, because capsule presentation is the format most easily misread. A capsule listing in this catalogue is a laboratory research material. It is not a supplement, it is not a medicine, and the format carries no implication of intended personal use. It is supplied, documented, and restricted on exactly the same terms as every vial in the range.
A blend is a single vial containing more than one compound, at a composition fixed at the point of manufacture rather than at the bench. The practical argument for a blend is that it removes handling steps, and every handling step removed is an opportunity for error removed with it. The practical argument against is that the ratio is no longer yours to vary. Where a protocol calls for a fixed, repeated combination, a blend is the cleaner option; where the ratio is itself a variable, it is not.
A stack is a set of separate vials supplied together. Each compound stays in its own container, retains its own lot number, and carries its own documentation, which means each can be prepared, stored, and accounted for independently. The distinction from a blend matters and is frequently blurred elsewhere: a stack is a purchasing convenience with full component visibility, while a blend is a manufacturing decision made in advance.
A small number of listings are supplied as prepared topical research solutions. These are formulated presentations intended for laboratory research work, and the formulation and concentration are part of what is supplied. As with every other format in the catalogue, they are not intended for human or animal use.
Bacteriostatic water is listed in several volumes under accessories. It is the kind of item that is easy to leave off an order and awkward to be without, which is why it sits in the catalogue alongside the compounds rather than being assumed.
Single-compound lyophilised vials make up the largest part of the catalogue. The table below indexes the listings by compound name and the nominal quantity of the standard presentation. Where a compound is offered in more than one quantity, the additional options are shown on its own product page. Quantities are listed as published; they are a specification, not a recommendation, and nothing in this index should be read as guidance on use.
| Listing | Format |
|---|---|
| ACE-031 | Vial, 1mg |
| Adamax | Vial, 5mg |
| Adipotide | Vial, 2mg |
| AICAR | Vial, 50mg |
| AMPK | Vial, 2mg |
| AOD-9604 | Vial, 2mg |
| ARA-290 | Vial, 2mg |
| B7-33 | Vial, 2mg |
| BPC-157 | Vial, 2mg |
| Bronchogen | Vial, 20mg |
| Cartalax | Vial, 20mg |
| CJC-1295 DAC | Vial, 2mg |
| CJC-1295 No DAC | Vial, 2mg |
| DSIP | Vial, 2mg |
| Epithalon | Vial, 10mg |
| Follistatin 344 | Vial, 1mg |
| FOXO4-DRI | Vial, 10mg |
| GDF-8 | Vial, 1mg |
| GHK-Cu | Vial, 5mg |
| GHRP-2 | Vial, 5mg |
| GHRP-6 | Vial, 5mg |
| Gonadorelin | Vial, 2mg |
| Hexarelin | Vial, 2mg |
| HMG | Vial, 75iu |
| Humanin | Vial, 10mg |
| IGF-1 LR3 | Vial, 0.1mg |
| Ipamorelin | Vial, 2mg |
| Kisspeptin | Vial, 5mg |
| KPV | Vial, 2mg |
| L-Glutathione | Vial, 200mg |
| LL-37 | Vial, 5mg |
| Melanotan I | Vial, 10mg |
| Melanotan II | Vial, 10mg |
| MGF | Vial, 2mg |
| MOTS-c | Vial, 10mg |
| NAD+ | Vial, 250mg |
| Orexin A | Vial, 5mg |
| Oxytocin | Vial, 2mg |
| P-21 | Vial |
| PEG-MGF | Vial |
| Pinealon | Vial |
| Protirelin (TRH) | Vial |
| PT-141 | Vial |
| PTD-DBM | Vial |
| Selank | Vial |
| Semax | Vial |
| Sermorelin | Vial |
| SNAP-8 | Vial |
| SS-31 | Vial |
| TB500 | Vial |
| Tesamorelin | Vial |
| Thymalin | Vial |
| Thymosin Alpha-1 | Vial, 10mg |
| Triptorelin | Vial, 2mg |
| Vilon | Vial, 20mg |
| VIP | Vial, 2mg |
Listings in this section span a wide range of compound classes, and several of them appear elsewhere in the catalogue in a second format. BPC-157, GHK-Cu, Epithalon, KPV, and Thymosin Beta 4 each appear as both a vial and a capsule listing, and several of the vial compounds also appear within blends and stacks. If you are comparing options for the same compound, the format sections above set out what practically changes between them.
Capsule listings are supplied in pre-portioned solid format with the nominal quantity per capsule published against each listing. They are research materials in the same sense as every vial in the catalogue, subject to the same restrictions, and they carry the same lot-linked documentation.
| Listing | Format |
|---|---|
| 5-Amino-1MQ | Capsules, 50mg |
| BPC-157 | Capsules, 500mcg |
| BPC-157 Thymosin Beta-4 | Capsules, 500mcg |
| Epithalon | Capsules, 1mg |
| GHK-Cu | Capsules, 2mg |
| KPV | Capsules, 250mcg |
| MK-677 | Capsules, 10mg |
| Tesofensine | Capsules |
| Thymosin Beta 4 | Capsules, 500mcg |
If you are choosing between a capsule and a vial listing of the same compound, the difference is control. A vial leaves preparation to you; a capsule fixes the portion at manufacture. Neither is inherently better, and the right answer follows from the study design rather than from convenience.
Combination listings fall into two clearly separated groups, and the catalogue keeps them separate for a reason. Blends are single vials with a fixed composition. Stacks are sets of separate vials. Reading one as the other leads to real confusion about what arrives, how it is documented, and how it should be stored.
Each blend listing states the compounds it contains and the total nominal quantity in the vial. Documentation is provided for each component, so what is in the vial remains inspectable rather than proprietary.
| Listing | Format |
|---|---|
| BPC-157 TB500 Blend | Vial, 20mg |
| GHRP-6 CJC-1295 DAC Blend | Vial, 2.5mg |
| GHRP-6 CJC-1295 No DAC Blend | Vial, 2.5mg |
| Ipamorelin CJC-1295 No DAC Blend | Vial, 2.5mg |
Stack listings supply their compounds as separate vials, each retaining its own identifier, lot number, and documentation. Where two compounds in a stack have different storage requirements, keeping them in separate containers is not merely tidier, it is the only way to store each correctly.
| Listing | Format |
|---|---|
| AOD-9604 BPC-157 Stack | Separate vials |
| BPC-157 GHK-Cu Thymosin Alpha-1 Stack | Separate vials |
| BPC-157 TB500 GHK-Cu Stack | Separate vials |
| BPC-157 VIP Stack | Separate vials |
| Epithalon DSIP Stack | Separate vials |
| GHK-Cu PTD-DBM Stack | Separate vials |
| GHK-Cu TB500 Stack | Separate vials |
| GHRP-2 CJC-1295 No DAC Stack | Separate vials |
| Kisspeptin PT-141 Stack | Separate vials |
| KPV BPC-157 Stack | Separate vials |
| LL-37 Thymosin Alpha-1 Stack | Separate vials |
| Oxytocin PT-141 Stack | Separate vials |
| Selank Semax Stack | Separate vials |
| Tesamorelin Ipamorelin Stack | Separate vials |
| Thymalin Epithalon Stack | Separate vials |
Several stacks pair compounds that also appear individually in the vial index, which means the same material can generally be bought either as a stack or as separate listings. The stack is a packaging and pricing convenience; it does not change what the individual components are or how they are documented.
The remaining listings cover prepared topical research solutions and the supporting laboratory items that an order may require alongside the compounds themselves.
| Listing | Format |
|---|---|
| GHK Basic Topical | Topical research solution |
| GHK-Cu Topical | Topical research solution, 200mg |
| Bacteriostatic Water | Laboratory accessory, multiple volumes |
Topical research solutions arrive already formulated, which means the solvent system and concentration have been set as part of the product rather than left to the researcher. Bacteriostatic water is stocked in several volumes because requirements differ considerably between a single reconstitution and sustained laboratory work.
A catalogue is only as good as the verification behind it, so it is worth stating plainly what supports these listings.
The range is presented on a standard of high-quality peptides at 99% purity or above for research use. Purity is assessed through independent analytical testing rather than asserted from a manufacturer's figure, and batch-specific analytical testing using HPLC and mass spectrometry supports the result. Those two techniques answer two different questions. Mass spectrometry addresses identity, establishing that the material is the sequence it is supposed to be. High-performance liquid chromatography addresses purity, measuring how much of the material is the compound itself and characterising what else is present.
Certificates of Analysis are provided for products, and batch-specific documentation accompanies the material. The word that matters in that sentence is batch-specific. A certificate that describes a compound in general, or an earlier production run, tells you very little about the vial in front of you. Documentation tied to the lot number printed on the unit tells you a great deal.
If you need documentation for a specific lot, whether for your own records, an internal review, a compliance file, or a methods section, quote the lot number when you ask. The contact page sets out what to include in that kind of enquiry.
Access to the website is restricted to users aged 21 or over. Products are supplied on the basis that the customer is associated with a body qualified to carry out laboratory research, including but not limited to a university, laboratory, or other research-based facility. Due diligence may be carried out and sales may be refused where the age requirement or the intended use appears questionable. This is set out in full in the Terms and Conditions, and it is a condition of purchase rather than a formality.
The published payment methods are Visa, Mastercard, Zelle, bank transfer, and cryptocurrency. Promotional codes are entered at the checkout stage, and the published policy is one voucher per order.
A window of two hours after purchase is published for order modifications. Beyond that point an order may already have been picked and packed, so a change cannot be assumed. If something is wrong with an order you have just placed, raise it immediately.
Orders are shipped worldwide, including to the USA and Europe, in plain packaging with tracking, and consolidated under a single shipping charge rather than one charge per item. Packaging is treated as the last stage at which the integrity of the material can be protected, which means the question at packing is not whether the parcel will look acceptable on arrival but whether the contents will still meet specification when the box is opened.
A seven-day window is published for reporting damaged items. Because of the nature of research materials and the need to maintain stock integrity, general returns are not accepted. Both positions are worth reading before ordering rather than after.
Goods crossing a border are subject to the rules of that border, and those rules differ by jurisdiction and change over time. Assistance with customs correspondence is provided where possible. Responsibility for confirming that a material may lawfully be imported into, and held for research in, your own jurisdiction rests with you and your institution, and responsibility for loss caused by non-compliance with the laws of the destination country is not accepted.
Purity at the point of manufacture is only part of the story, and it is the part a supplier controls. What happens after the box is opened determines whether that purity is still meaningful when the material is used.
Storage requirements vary by compound, by format, and by whether material is still lyophilised or has been reconstituted, so the product-specific information supplied with an order is the authority rather than a general rule. What can be said generally is that a material stored badly is no longer described by its certificate, and no documentation can rescue it.
Responsible handling in a laboratory setting means following institutional safety protocols, storing material under conditions appropriate to the compound, avoiding contamination, keeping accurate records of what was used and from which lot, and operating within applicable laws and institutional guidelines. Materials in this catalogue should be handled only by qualified personnel in suitable research environments.
Nothing on this page, and nothing supplied with an order, constitutes dosage information, administration instructions, protocols, or guidance on use in humans or animals. That boundary is explained further on the contact page, and the research categories these materials relate to are set out on the services page.
Eighty-seven listings is enough to be genuinely useful and enough to be briefly overwhelming. A few practical points shorten the process.
New arrivals and promotions are movable sections and are worth checking against the main listing rather than treated as separate ranges. A compound appearing under new arrivals is the same material, documented the same way, as one that has been listed for a year.
Beyond the format groupings, the catalogue offers two other ways in, and which one is faster depends entirely on whether you already know what you are looking for.
The first is alphabetical. Compounds are grouped by initial letter into four bands, A to E, F to K, L to P, and Q to Z, which is the quickest route when you have a compound name in hand and simply want to reach its listing. The A to E band covers listings from 5-Amino-1MQ and ACE-031 through to Epithalon; F to K runs from Follistatin 344 to Kisspeptin; L to P covers LL-37 through PT-141; and Q to Z holds Selank, Semax, Sermorelin, TB500, Thymosin Alpha-1, VIP and the rest of the later alphabet.
The second is sorting within a listing view. The published options are the default order, popularity, average rating, most recent, and price in either direction. Sorting by newest is the practical way to see what has been added without treating new arrivals as a separate range, and sorting by price is useful when comparing quantity options across similar listings. Neither sort changes what a product is or how it is documented, which sounds obvious but is worth saying, because a listing ranked highly by popularity is not thereby better suited to a particular piece of work.
If neither route finds what you need, the compound may be one that is not currently stocked. That is worth an enquiry rather than an assumption, and the answer will be a straight yes or no.
This page describes materials, formats, and documentation. It deliberately does not attach a research application to each individual compound, and the reason is worth stating rather than leaving implied.
Assigning a purpose to a compound on a shop page is how a research catalogue quietly turns into a consumer one. A short line describing what a peptide is "for" reads as a claim, whether or not it was intended as one, and it invites exactly the interpretation that research-use positioning exists to prevent. The catalogue therefore describes what is in the vial, not what it might be expected to achieve.
The broader research categories that peptide work falls into, sixteen of them, are set out separately on the services page, written as scientific categories rather than as outcomes. The background on purity standards, independent testing, batch documentation, packaging, and the reasoning behind the supply model is on the about page. Between the two, most questions about why the catalogue looks the way it does are already answered, and the contact page covers the rest.
Eighty-seven listings, indexed on this page by format. Because several compounds appear in more than one format, the number of distinct compounds is lower than the number of listings.
The range is presented on a standard of high-quality peptides at 99% purity or above for research use, assessed through independent analytical testing, with batch-specific HPLC and mass spectrometry supporting the Certificates of Analysis provided for products.
Because prices and promotions change, and a figure reproduced here would eventually be wrong. Pricing, quantity options, and current promotions are shown against each listing on the website, which is the accurate source at any given moment.
A blend is one vial containing more than one compound, at a composition fixed when it was made. A stack is a set of separate vials supplied together, each with its own lot number and documentation. A blend fixes the ratio for you; a stack leaves it with you.
Ask. Sometimes it can be sourced to a standard worth standing behind and sometimes it cannot, and the answer will be the real one rather than an order accepted in hope.
No. It is a separate listing under accessories, available in several volumes. Adding it to the same order is more economical than a second consignment, since shipping is consolidated under one charge.
No. Identity, purity, format, documentation, packaging, and storage are all answerable. Study design, compound selection against a hypothesis, and anything touching on use in humans or animals are not.
No. Format carries no implication of intended use. Capsule listings are laboratory research materials on exactly the same terms as every vial in the catalogue.
All products on this website are supplied for laboratory research purposes only. They are not intended for human or animal consumption or ingestion of any kind, and they are not medicines or drugs approved by any medicines regulator for the diagnosis, treatment, cure, or prevention of any condition. Nothing on this page constitutes medical advice, dosage guidance, administration instructions, or a recommendation of any kind regarding use. All materials should be handled only by qualified professionals in suitable laboratory environments and in accordance with applicable laws, regulations, and institutional policies. Purchases are subject to the Terms and Conditions and the Privacy Policy.